CA
NZ
UK
AU
IND
US
Enova International, Inc. filed a current report on Form 8-K on September 15, 2026, disclosing that its indirect subsidiary OnDeck Asset Securitization IV, LLC announced a proposed private securitization of $500,026,000 in fixed-rate asset-backed notes, with closing anticipated on or about September 25, 2026.
Uber Technologies, Inc. filed a current report on Form 8-K on September 15, 2026, disclosing the completion of a registered public offering of five tranches of euro-denominated senior unsecured notes totaling €4,500,000,000 in aggregate principal amount.
A Form 4 filed on September 15, 2026, reports that Jill Hazelbaker, President and Chief Corporate Affairs Officer of Uber Technologies, Inc. (NYSE:UBER), disposed of 28,170 shares of common stock on September 11, 2026.
A Form 4 filed on September 15, 2026 discloses that Morris Goldfarb, CEO and Director of G III Apparel Group Ltd /DE/ (NASDAQ:GIII), purchased 40,000 shares of common stock on September 14, 2026 at a weighted average price of $27.94 per share.
Benjamin Haycraft, Chief Strategy Officer and GM EMEA of Plug Power Inc., filed a Form 4 on September 15, 2026, reporting two sales of common stock executed under a pre-established Rule 10b5-1 trading plan.
Director Sami Gabriel Khouri filed a Form 4 with the SEC on September 15, 2026, reporting a disposition of Class A Common Shares of BBB Foods Inc. (NYSE:TBBB) dated September 14, 2026.
A Form 4 filed on September 15, 2026 with the U.S. Securities and Exchange Commission discloses that Robert S. Keane, CEO and Chairman of Cimpress plc (NASDAQ:CMPR), sold a combined 28,000 ordinary shares on September 11, 2026, across both direct and indirect holdings.
Fred Aslan, Chief Executive Officer and Director of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV), filed a Form 4 on September 15, 2026, reporting the acquisition of restricted stock units and stock options under the company's 2024 Equity Incentive Plan.
Leroy T. Carlson Jr., Vice Chair and Director of Telephone & Data Systems Inc /DE/, filed a Form 4 on September 15, 2026, reporting transactions in Common Shares dated September 11, 2026, on the exchange listed as NYSE:TDS.
Annette F. Favorite, Senior Vice President and Chief Human Resources Officer of West Pharmaceutical Services Inc., filed a Form 4 on September 15, 2026, reporting the exercise of stock options and concurrent sales of common stock on September 11, September 14, and September 15, …
Please wait processing your request...